Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause Mortality in Patients Beginning Hemodialysis
NCT00457561 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2007-04-06
Summary
Decreased body fat mass, possibly mediated through the effects of elevated serum adiponectin levels, may be associated with requirements for higher recombinant human erythropoietin doses and a subsequent worse prognosis in patients beginning hemodialysis.
Conditions
- Hemodialysis
Sponsors & Collaborators
-
Hamamatsu University
lead OTHER
Principal Investigators
-
Naro Ohashi, MD,PhD · First Department of Medicine, Hamamatsu University School of Medicine
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
The Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients
NCT03286712 ·Status: COMPLETED ·Phase: PHASE4
-
Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients
NCT05699109 ·Status: COMPLETED
-
Renal Anemia Refractory to Erythropoietin
NCT03480178 ·Status: UNKNOWN
-
Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents
NCT02136563 ·Status: COMPLETED
-
Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia
NCT00563446 ·Status: COMPLETED ·Phase: NA
-
Study of Erythropoietin (EPO) Administration Schedule
NCT01111630 ·Status: COMPLETED ·Phase: PHASE4
-
Renal Effects of Erythropoietin in Humans
NCT01584921 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Human Recombinant Erythropoietin in Acute Renal Failure
NCT03102021 ·Status: COMPLETED ·Phase: PHASE2
-
Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients
NCT01049711 ·Status: COMPLETED
-
Evaluate the Efficacy and Safety of HIF-PHI for the Treatment of Anemia and Risks of Cardiovascular and Cerebrovascular Events in ESRD Newly Initiated Dialysis Patients
NCT04134026 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.
NCT00752609 ·Status: COMPLETED ·Phase: PHASE2
-
Mean Reticulated Haemoglobin (Hb) Content (RetHe) Analysis of Renal Patients
NCT01126905 ·Status: COMPLETED
-
" Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Outcomes, and Metabolic Syndrome as a Risk Factor for Erythropoietin Resistance "
NCT06983756 ·Status: NOT_YET_RECRUITING
-
Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease
NCT01719146 ·Status: COMPLETED
-
A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients
NCT00563355 ·Status: COMPLETED ·Phase: NA
-
The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) Disease
NCT00446576 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
NCT03439137 ·Status: COMPLETED ·Phase: PHASE3
-
Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity
NCT00744445 ·Status: COMPLETED ·Phase: PHASE2
-
Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)
NCT00156962 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluating the Effect of Standard-of-care Erythropoiesis-stimulating Agents on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease.
NCT02987465 ·Status: COMPLETED
-
Erythropoietin (EPO) and Ischemia-reperfusion After Kidney Transplantation
NCT00425698 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease
NCT00440557 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
NCT03461146 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients
NCT00261521 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis
NCT02253654 ·Status: COMPLETED ·Phase: PHASE4